General Mills (GIS) Q3 FY2026: The Yogurt Hangover — Is the Pain Finally Priced In?
Published on: Wed Mar 18 2026
General Mills ($GIS) finds itself in an uncomfortable but potentially interesting place for investors: a 100-year-old consumer staples franchise trading near its lowest valuation in a decade, facing headwinds that are largely self-inflicted and arguably temporary. Q3 FY2026 results, reported March 18, were messy — adjusted EPS of $0.64 missed the $0.73 consensus by 12%, revenue declined 8% year-over-year to $4.44 billion, and the full-year EPS guidance implies a 16–20% decline in constant currency.
The culprit isn’t the brands. Cheerios, Häagen-Dazs, Nature Valley, Blue Buffalo — these remain category leaders with durable consumer loyalty. The culprit is a botched portfolio transition: General Mills sold its $2.1 billion North American yogurt business but failed to strip out the overhead supporting it, leaving $300M+ in “stranded costs” dragging through the P&L. Add $200 million in new tariff costs from 2026 trade policy, and you have a painful but arguably finite earnings trough.
The question every investor needs to answer: Is this a cyclical reset, or has something structurally broken?
Results at a Glance
| Metric | Q3 FY2026 | Q3 FY2025 | vs. Estimate |
|---|---|---|---|
| Net Sales | $4.44B | $4.84B | In line ($4.42B est.) |
| Organic Net Sales | −1.8% | +1.5% | |
| Adjusted EPS | $0.64 | $0.92 | −12% miss ($0.73 est.) |
| Adjusted Op. Profit Margin | 16.5% | 17.7% | −120 bps |
| Net Earnings (GAAP) | $303M | $634M | −52% YoY |
| Diluted EPS (GAAP) | $0.56 | $1.12 | −50% YoY |
The GAAP EPS collapse (−50%) is jarring but largely accounting-driven: it reflects charges from the yogurt divestiture and joint venture adjustments. The 12% adjusted EPS miss is the more operative signal — and it reflects real cash costs that are hitting the business now.
Revenue: A Portfolio in Transition
The 8% revenue decline is not as bad as it looks. The bulk of the drop is attributable to the divestiture of North American Yogurt in FY2025 — a $1.5B revenue business that is no longer in the portfolio. On an organic basis (apples-to-apples, same portfolio), sales declined only 1.8%.
Annual Net Sales (in $B) — FY2022 to FY2026E
FY2022–FY2025 actuals. FY2026E reflects yogurt divestiture impact (~−$1.5B) plus organic sales decline of ~1.5–2%. GIS fiscal year ends in May.
The revenue decline from FY2023’s peak of $20.1 billion is real and structural in the near term. But context matters: FY2023’s $20B included the yogurt business that has now been sold. The remaining portfolio — cereals, snacking, pet food, ice cream — is smaller but arguably cleaner. The Brazil business sale announced March 16 will reduce revenue further, though it’s expected to be completed by end of 2026.
Free Cash Flow: The Underappreciated Anchor
Despite the earnings miss, General Mills’ free cash flow generation remains substantial. Management guided for 95%+ free cash flow conversion for FY2026. With guided EPS implying net income of roughly $1.7–$1.9B, FCF should land in the $1.6–$1.8B range for FY2026.
Free Cash Flow (in $B) — FY2022 to FY2026E
FY2026E estimate based on 95%+ management FCF conversion guidance. FCF peaked in FY2022 before the portfolio transition.
Even at ~$1.7B, General Mills generates more free cash flow per dollar of market cap than most consumer staples peers. At a $20.5B market cap, the stock trades at roughly 12x FY2026E FCF — a multiple that reflects all the current headwinds but arguably prices in limited recovery.
Organic Sales Trend: Volume Erosion Is the Core Problem
The 1.8% organic sales decline in Q3 masks an important distinction: price/mix was positive (+1.2%), but volume fell 3%. This is not a one-quarter blip — it is the third consecutive quarter of negative volume:
Organic Net Sales Growth — by Component (YoY)
Volume declines have accelerated through FY2026 as price investments lag cost pressures. Trend bears watching into FY2027.
Volume erosion accelerating from −2% in Q1 to −3% in Q3 is the most concerning trend in the report. It suggests consumers are substituting away from General Mills brands — particularly in cereal and snacking — possibly toward private label or competing formats. CEO Jeff Harmening acknowledged the challenge but pointed to product innovation launches and packaging investments as the path to recovery. Those typically take 3–6 quarters to show in the data.
The Yogurt Hangover: Stranded Costs Explained
In FY2025, General Mills sold its North American Yogurt business (Yoplait, Liberté) to Lactalis for approximately $2.1 billion. The strategic logic was sound: yogurt had thin margins, required heavy trade spending, and was losing market share to Greek/protein-focused competitors.
The execution problem: the sale removed ~$1.5 billion in revenue and the manufacturing assets, but the corporate infrastructure supporting that revenue did not immediately disappear. Corporate overhead (procurement, logistics, HR, IT systems), regional distribution footprint, and management layers that existed to support the yogurt business are still on the books.
These “stranded costs” are estimated at $300–400M annually until fully rightsized. Management says the cost reduction program is on track with the majority addressed by mid-FY2027 — but it creates a multi-quarter drag that isn’t related to underlying brand health.
The Brazil business sale announced March 16 follows the same playbook — divest non-core, simplify the portfolio — and adds to near-term revenue and cost complexity before it simplifies.
Adjusted Operating Margin Trend
Adjusted Operating Profit Margin — FY2022 to Q3 FY2026
Adjusted operating margin has compressed ~300bps since FY2022 peak, primarily driven by stranded costs and input cost inflation.
The margin compression from ~19.5% in FY2022 to 16.5% in Q3 FY2026 represents the entire drag from the portfolio transition. The pre-divestiture business ran at high-teens margins; the post-divestiture transition period is running at mid-teens. If management successfully removes the stranded costs by FY2027 and input cost inflation moderates, margins could recover toward 18–19% — which would be a significant earnings catalyst.
Portfolio Reshaping: What’s Left After the Divestitures
The remaining General Mills business, post-yogurt sale and Brazil sale, concentrates around four core platforms:
- North America Retail (~52% of sales): Cereals (Cheerios, Wheaties, Lucky Charms), Snacking (Nature Valley, Fiber One), Meals & Baking (Pillsbury, Betty Crocker), Ice Cream (Häagen-Dazs in international markets)
- North America Foodservice (~17% of sales): Institutional baking, cereal portions, flour
- International (~19% of sales): Häagen-Dazs super-premium ice cream (key growth platform), Old El Paso Mexican food, snack bars
- North America Pet (~12% of sales): Blue Buffalo (premium pet food — the hidden gem of the portfolio)
Blue Buffalo deserves particular attention. Acquired for $8 billion in 2018, Blue Buffalo now commands the #1 position in premium dry dog food — a segment that has proven remarkably resilient even in consumer downturns, as pet owners tend to maintain premium pet food spending even as they trade down on their own groceries. This business alone generates estimated $600-700M in annual segment operating profit and trades at a premium in pet food M&A comparables (Purina, Mars, etc. have paid 18-25x EBITDA for pet food brands). At the blended GIS multiple, Blue Buffalo is arguably being valued at a discount.
Valuation
| Metric | Value |
|---|---|
| Stock Price (as of March 18) | ~$38.50 |
| 52-Week Range | $37.97 – $62.61 |
| Market Cap | ~$20.5B |
| Enterprise Value | ~$33.5B |
| FY2026E Adj. EPS | ~$3.37 |
| Forward P/E | ~11.4x |
| TTM FCF (FY2025) | $2.29B |
| FY2026E FCF | ~$1.7B |
| P/FY2026E FCF | ~12x |
| EV / FY2026E FCF | ~20x |
| P/S (FY2026E revenue) | ~1.1x |
| Dividend | $2.24/share annually |
| Dividend Yield | ~5.8% |
| Long-Term Debt | $13.7B |
| Avg. Analyst Price Target | $49.38 |
| Implied Upside to Target | ~28% |
The bull case: General Mills is trading at roughly 11x forward earnings and yielding ~5.8% — historically cheap for a Dividend Aristocrat with 27 consecutive years of dividend increases. If the stranded costs from the yogurt divestiture are properly eliminated by mid-FY2027 (as management targets), operating margins should recover toward 18–19%, implying $4.50+ in adjusted EPS — putting the stock at under 9x that normalized earnings. Blue Buffalo alone, valued at peer pet food multiples, could be worth $15–18B (the entire current market cap). The $200M tariff headwind is also not permanent — trade policy changes are possible. The stock pricing in peak pessimism with 28% upside to average analyst targets looks like an opportunity.
The bear case: Volume erosion is accelerating (-2% → -2.5% → -3% over three quarters) and may not be entirely attributable to the portfolio transition. Secular shifts toward protein, fresh food, and GLP-1 dietary changes (which suppress appetite for exactly the kinds of snacking and cereal products GIS sells) could represent a structural headwind to cereal and snacking volumes that pricing cannot offset. The $13.7 billion in long-term debt (debt/equity of 147%) limits balance sheet flexibility and makes this a leveraged bet on a turnaround. If the cost structure doesn’t right-size as planned, or if Blue Buffalo faces competitive pressure from Purina’s premium expansion, estimates could still come down. Management has repeatedly underdelivered on the margin recovery timeline.
What to watch next quarter: (1) Volume trends in Q4 FY2026 — does the deceleration stop, and does the brand investment starting to show in scanner data? (2) Stranded cost progress — any specific dollar figure on how much overhead has been eliminated would reset sentiment. (3) Blue Buffalo growth rate — this is the franchise that justifies the thesis. If pet food volumes start declining, the bull case loses its anchor. (4) Any tariff mitigation commentary — $200M in new tariff costs is a known quantity, but management’s ability to offset through procurement or pricing will determine the FY2027 setup.
This article is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions.